RxDoctor Payments Data

Anne Maestas, DPM

Foot & Ankle Surgery · Troy, MONPI 1033569132

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.0%), education and other — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Organogenesis Inc. at 25.1% of the total. Reporting peaked in 2019 at $5,293 and has fallen 70.2% since, to $1,576 in 2025.

$12,675in general payments, 2019–2025

Across 178 payments — averaging $71.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$3K
  • Elite Orthopedics, LLC$3K
  • Arthrex$2K
  • Kerecis Limited$1K
  • Stryker$859
  • Integra Lifesciences Corporation$642
  • plus $2K from 12 others

What the payments were for

  • Travel & lodging$10%
  • Food & beverage$7,34758%
  • Education$4,90139%
  • Other$4273%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,675 in reported general payments places this provider in the 65th percentile of 163 foot & ankle surgery providers in Missouri.

See all foot & ankle surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$56,040
Medicare patients
239
Services billed
1,046

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox69$1,696
Ketoconazole25$616
Terbinafine Hcl19$482
Doxycycline Monohydrate22$404
Gabapentin23$211
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$141
Mupirocin13$117
Methylprednisolone12$68

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Troy

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →